RESOLUTE-III all-comers trial: A randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention.
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2014
At a glance
- Drugs Zotarolimus (Primary) ; Everolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms RESOLUTE-All comers; RESOLUTE-III All comers
- Sponsors Medtronic
- 31 Aug 2018 Biomarkers information updated
- 05 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 31 Jan 2014 Results published in the Journal of the American College of Cardiology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History